Skip to content

Non-invasive Evaluation of Volume Status Using Exhaled Carbon Dioxide and Pulse Contour Analysis

Non-invasive Volume Evaluation With Exhaled Carbon Dioxide and Pulse Contour Analysis (Nexfin)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02070861
Enrollment
33
Registered
2014-02-25
Start date
2014-04-30
Completion date
2015-06-30
Last updated
2018-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Changes in Cardiac Output

Keywords

Cardiac output, Exhaled CO2, Nexfin, Esophageal Doppler

Brief summary

The investigators hypothesize that changes in blood circulation can be reflected by exhaled CO2 provided CO2-production in the tissues and ventilation from the lungs are stable. The investigators want to explore changes in cardiac output (the amount of blood being pumped out of the heart each minute) in patients using different devices: an esophagus ultrasound device measuring cardiac output, a finger cuff measuring blood pressure and cardiac output, and exhaled carbondioxide in the patients' breath measured by the ventilator. The investigators investigate patients after bypass surgery or heart valve replacement, and induce changes in cardiac output with passive leg raise or ventricular pacing.

Detailed description

Measurements with the finger cuff (pulse contour analyses) were aborted due to technical difficulties.

Interventions

OTHERVentricular pacing and passive leg raise

Ventricular pacing and passive leg raise

Sponsors

The Norwegian Air Ambulance Foundation
CollaboratorUNKNOWN
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Persons 18 years or older scheduled to undergo arteriocoranary bypass surgery or aortic valve replacement.

Exclusion criteria

* Esophageal pathology, EF \<40%

Design outcomes

Primary

MeasureTime frame
Changes in cardiac output5 Minutes

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026